貴州茅台(600519.SH)跌破1900元關口 跌穿年線
格隆匯7月23日丨貴州茅台(600519.SH)跌超2%至1895.09元,創5月以來新低,且跌穿年線,較今年2月份的歷史最高價2603.37元跌27.2%,最新市值2.38萬億元。公募基金披露的二季報顯示,雖然前十大重倉股中茅台依舊排第一,但整體仍遭遇大手筆減持。另外,目前全球持有貴州茅台最多的基金公司——美國資本集團公佈二季度持倉數據顯示,資本集團旗下歐洲亞太成長基金和新世界基金均減持了貴州茅台。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.